Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4 publications
Analysis of on-treatment cancer safety events with daprodustat versus conventional erythropoiesis-stimulating agents-post hoc analyses of the ASCEND-ND and ASCEND-D trials.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: August 12, 2022
Three Times Weekly Dosing of Daprodustat versus Conventional Epoetin for Treatment of Anemia in Hemodialysis Patients: ASCEND-TD: A Phase 3 Randomized, Double-Blind, Noninferiority Trial.
Journal: Clinical journal of the American Society of Nephrology : CJASN
Published: January 14, 2022
Daprodustat for the Treatment of Anemia in Patients Not Undergoing Dialysis.
Journal: The New England journal of medicine
Published: November 05, 2021
The ASCEND-ND trial: study design and participant characteristics.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: July 23, 2021
Showing 1-4 of 4
Last Updated: 09/26/2026